Anavex Life Sciences Corp (AVXL)
3.835
+0.08
(+1.99%)
USD |
NASDAQ |
May 03, 16:00
3.835
0.00 (0.00%)
After-Hours: 18:27
Anavex Life Sciences Cash from Operations (Quarterly): -7.318M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.318M |
| September 30, 2023 | -5.850M |
| June 30, 2023 | -7.652M |
| March 31, 2023 | -8.489M |
| December 31, 2022 | -5.794M |
| September 30, 2022 | -4.044M |
| June 30, 2022 | -7.054M |
| March 31, 2022 | -9.640M |
| December 31, 2021 | -3.501M |
| September 30, 2021 | -7.675M |
| June 30, 2021 | -7.521M |
| March 31, 2021 | -7.317M |
| December 31, 2020 | -7.871M |
| September 30, 2020 | -6.255M |
| June 30, 2020 | -4.044M |
| March 31, 2020 | -5.263M |
| December 31, 2019 | -5.725M |
| September 30, 2019 | -2.534M |
| June 30, 2019 | -7.501M |
| March 31, 2019 | -4.332M |
| December 31, 2018 | -4.160M |
| September 30, 2018 | -4.053M |
| June 30, 2018 | -2.088M |
| March 31, 2018 | -2.821M |
| December 31, 2017 | -3.620M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.192M |
| June 30, 2017 | -2.974M |
| March 31, 2017 | -0.6977M |
| December 31, 2016 | -3.154M |
| September 30, 2016 | -1.863M |
| June 30, 2016 | -2.224M |
| March 31, 2016 | -1.903M |
| December 31, 2015 | -3.247M |
| September 30, 2015 | -1.433M |
| June 30, 2015 | -1.430M |
| March 31, 2015 | -0.6703M |
| December 31, 2014 | -0.6931M |
| September 30, 2014 | -0.9169M |
| June 30, 2014 | -0.96M |
| March 31, 2014 | -0.3475M |
| December 31, 2013 | -0.435M |
| September 30, 2013 | -0.4845M |
| June 30, 2013 | -0.0322M |
| March 31, 2013 | -0.1293M |
| December 31, 2012 | -0.1316M |
| September 30, 2012 | -0.2519M |
| June 30, 2012 | -0.2387M |
| March 31, 2012 | -0.1142M |
| December 31, 2011 | -1.088M |
| September 30, 2011 | -0.9226M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.640M
Minimum
Mar 2022
-2.534M
Maximum
Sep 2019
-6.371M
Average
-7.054M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Ventyx Biosciences Inc | -51.66M |
| Checkpoint Therapeutics Inc | -6.833M |
| Vertex Pharmaceuticals Inc | 234.60M |
| Sarepta Therapeutics Inc | -242.08M |
| NovaBay Pharmaceuticals Inc | -0.314M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.059M |
| Free Cash Flow | -29.31M |
| Free Cash Flow Per Share (Quarterly) | -0.0892 |
| Free Cash Flow Yield | -9.46% |